X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15414) 15414
Publication (4090) 4090
Book Review (191) 191
Book Chapter (89) 89
Dissertation (53) 53
Conference Proceeding (31) 31
Book / eBook (22) 22
Magazine Article (19) 19
Data Set (11) 11
Journal / eJournal (6) 6
Government Document (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
Newspaper Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11427) 11427
index medicus (7516) 7516
hiv-1 - immunology (6227) 6227
immunology (5566) 5566
virology (5377) 5377
animals (5328) 5328
hiv (4860) 4860
hiv-1 (4211) 4211
hiv infections - immunology (3923) 3923
infectious diseases (3893) 3893
female (3892) 3892
hiv-1 - genetics (3707) 3707
viruses (3162) 3162
hiv infections - virology (2904) 2904
male (2872) 2872
aids vaccines - immunology (2782) 2782
infection (2722) 2722
human immunodeficiency virus--hiv (2495) 2495
human-immunodeficiency-virus (2463) 2463
virus diseases (2445) 2445
aids (2375) 2375
molecular sequence data (2297) 2297
adult (2231) 2231
research (2210) 2210
immunodeficiency-virus type-1 (2208) 2208
vaccines (2149) 2149
mice (2049) 2049
amino acid sequence (1958) 1958
health aspects (1954) 1954
infections (1893) 1893
microbiology (1877) 1877
hiv infections - prevention & control (1853) 1853
research article (1718) 1718
human immunodeficiency virus (1658) 1658
hiv-1 - physiology (1651) 1651
hiv infection (1640) 1640
aids vaccines (1631) 1631
article (1610) 1610
hiv antibodies - immunology (1573) 1573
antibodies (1552) 1552
vaccination (1521) 1521
viral load (1514) 1514
multidisciplinary sciences (1490) 1490
acquired immune deficiency syndrome--aids (1475) 1475
vaccine (1464) 1464
immunization (1454) 1454
medicine, research & experimental (1443) 1443
hiv envelope protein gp120 - immunology (1387) 1387
proteins (1379) 1379
medicine (1324) 1324
middle aged (1275) 1275
hiv-1 infection (1254) 1254
cell line (1232) 1232
t cells (1188) 1188
hiv infections - drug therapy (1180) 1180
lymphocytes (1174) 1174
neutralization tests (1162) 1162
biology (1116) 1116
analysis (1097) 1097
hiv-1 - drug effects (1096) 1096
cd4-positive t-lymphocytes - immunology (1085) 1085
immune response (1078) 1078
disease progression (1074) 1074
immune-responses (1062) 1062
cd8-positive t-lymphocytes - immunology (1060) 1060
neutralizing antibodies (1059) 1059
acquired immune deficiency syndrome (1035) 1035
science (1031) 1031
mutation (1002) 1002
mice, inbred balb c (981) 981
antigens (968) 968
dendritic cells (945) 945
hiv-1 - isolation & purification (945) 945
antibodies, neutralizing - immunology (935) 935
physiological aspects (923) 923
biochemistry & molecular biology (916) 916
hiv-1 - classification (915) 915
hiv antibodies - blood (914) 914
antiretroviral therapy (912) 912
genetic aspects (904) 904
in-vivo (904) 904
t-lymphocytes, cytotoxic - immunology (904) 904
replication (899) 899
aids vaccines - administration & dosage (892) 892
macaca mulatta (891) 891
type-1 (834) 834
vaccines and antiviral agents (830) 830
hiv infections - epidemiology (825) 825
epitopes - immunology (813) 813
medical research (807) 807
enzyme-linked immunosorbent assay (806) 806
phylogeny (798) 798
cells, cultured (793) 793
virus replication (792) 792
epitopes (780) 780
envelope glycoprotein (775) 775
simian immunodeficiency virus - immunology (771) 771
responses (770) 770
immunity (753) 753
hiv-1 - pathogenicity (745) 745
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15322) 15322
French (45) 45
Chinese (38) 38
Spanish (29) 29
German (28) 28
Russian (28) 28
Japanese (26) 26
Korean (6) 6
Portuguese (6) 6
Italian (5) 5
Polish (3) 3
Dutch (2) 2
Swedish (2) 2
Bulgarian (1) 1
Czech (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 46, pp. 8417 - 8428
Highlights ► A phase I/II HIV vaccine trial has been conducted in Tanzania employing priming with HIV-1 DNA and boosting HIV-1 MVA. ► It has demonstrated... 
Allergy and Immunology | MVA boost | DNA prime | HIV vaccine | MEDICINE, RESEARCH & EXPERIMENTAL | VACCINIA VIRUS ANKARA | PHASE-1 SAFETY | IMMUNOGENICITY EVALUATION | CLADE-C | IMMUNOLOGY | DAR-ES-SALAAM | T-CELL RESPONSES | DOUBLE-BLIND | SMALLPOX VACCINATION | CANDIDATE VACCINE | MONOCLONAL-ANTIBODIES | Vaccines, DNA - genetics | Cell Proliferation | Humans | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Male | Neutralization Tests | Vaccines, Synthetic - immunology | Human Experimentation | Vaccines, DNA - administration & dosage | Vaccinia virus - genetics | Drug Carriers | Young Adult | Acquired Immunodeficiency Syndrome - immunology | Vaccination - methods | Leukocytes, Mononuclear - immunology | Adult | Female | Acquired Immunodeficiency Syndrome - virology | Placebos - administration & dosage | Injections, Intradermal | Interferon-gamma - secretion | Vaccines, Synthetic - genetics | Tanzania | Acquired Immunodeficiency Syndrome - prevention & control | Viral Proteins - genetics | Immunization, Secondary - methods | Enzyme-Linked Immunospot Assay | HIV-1 - genetics | Viral Vaccines - administration & dosage | HIV-1 - immunology | Plasmids | Adolescent | AIDS Vaccines - genetics | Vaccines, Synthetic - administration & dosage | AIDS Vaccines - administration & dosage | Genetic Vectors | Viral Vaccines - immunology | Interferon-gamma - biosynthesis | Viral antibodies | AIDS vaccines | Immune response | DNA | Vaccination | Antibodies | Universities and colleges | HIV (Viruses) | Biometry | Vaccines | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Immunization | CD8 antigen | Immune response (cell-mediated) | DNA vaccines | Lymphocytes T | Corticotropin-releasing hormone | CD4 antigen | glycoprotein gp160 | Gag protein | Immunogenicity | Interleukin 2 | Lymphocytes | Peripheral blood mononuclear cells | Serological tests | Enzyme-linked immunosorbent assay
Journal Article
Vaccine, ISSN 0264-410X, 2007, Volume 25, Issue 20, pp. 4085 - 4092
Abstract Needle-free delivery of a six-plasmid HIV-1 DNA vaccine encoding EnvA, EnvB, EnvC, and subtype B Gag, Pol, and Nef underwent open-label evaluation in... 
Allergy and Immunology | Promoter | Prevention | T cell response | AIDS | Envelope | Gag | Pol | Nef | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | VIRUS | SAFETY | HUMANS | IMMUNOGENICITY EVALUATION | INDUCTION | IMMUNOLOGY | VECTOR | IMMUNIZATION | envelope | VETERINARY SCIENCES | promoter | MONKEYS | MEMORY T-CELLS | prevention | HIV Infections - prevention & control | Vaccines, DNA - genetics | Gene Products, env - immunology | Humans | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Male | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Vaccines, DNA - administration & dosage | AIDS Vaccines - adverse effects | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV Antibodies - immunology | Plasmids - genetics | HIV Antibodies - biosynthesis | Vaccines, Combined - genetics | Adult | Female | Gene Products, gag - immunology | HIV Infections - virology | Plasmids - immunology | HIV-1 - genetics | Immunity, Cellular - immunology | HIV-1 - immunology | Vaccines, Combined - adverse effects | Vaccines, DNA - adverse effects | Adolescent | AIDS Vaccines - genetics | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Gene Products, nef - immunology | nef Gene Products, Human Immunodeficiency Virus | Proteins | AIDS vaccines | T cells | HIV (Viruses) | DNA | Enzyme-linked immunosorbent assay | Vaccines | Acquired immune deficiency syndrome--AIDS | Plasmids | Laboratories | Human immunodeficiency virus--HIV
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 12/2018, Volume 104, Issue 6, pp. 1062 - 1073
Human immunodeficiency virus (HIV) has infected 76 million people and killed an estimated 35 million. During its 40‐year history, remarkable progress has been... 
VAGINAL SHIV CHALLENGE | CYTOPLASMIC DOMAIN | BROADLY NEUTRALIZING ANTIBODIES | EFFICACY TRIAL | IMMUNE-RESPONSES | HIV-1 PREVENTIVE VACCINE | EFFECTOR FUNCTION | IMMUNODEFICIENCY-VIRUS TYPE-1 | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | ENVELOPE PROTEIN | State of the Art | Reviews
Journal Article
Advanced Materials, ISSN 0935-9648, 11/2013, Volume 25, Issue 41, pp. 5928 - 5936
Journal Article
Journal Article